SEB Asset Management’s Astera Labs ALAB Stock Holding History

SEB Asset Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20M	Buy	41,368 +4,638	+13%	+$1.23M	0.08%	220
2026 Q1	$4.03M	Buy	+36,730	New	+$5.23M	0.02%	490

Other funds holding ALAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

SEB Asset Management's ALAB Position: Q2 2026 in Review

SEB Asset Management increased its Astera Labs (ALAB) stake by 13% in Q2 2026, buying an estimated $1.23M and bringing the position to 41,368 shares worth $20M. The position accounts for 0.08% of the portfolio, ranked #220.

SEB Asset Management first reported a position in ALAB in Q1 2026 and has held it in 2 quarters since. 918 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

SEB Asset Management held 41,368 shares of Astera Labs worth $20M as of Q2 2026.
SEB Asset Management bought 4,638 Astera Labs shares in Q2 2026, an estimated $1.23M.
Astera Labs made up 0.08% of SEB Asset Management's portfolio in Q2 2026, its #220 holding.
SEB Asset Management first reported a position in Astera Labs in Q1 2026 and has held it in 2 quarters since.
918 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.